HIV News and Research

RSS

New approach for delivering vaccines and for stimulating body's immune system to attack tumors

Many vaccines, including those for influenza, polio, and measles, consist of a killed or disabled version of a virus. However, for certain diseases, this type of vaccine is ineffective, or just too risky.

18 Feb 2014

Valproic acid metabolism and obesity: an interview with Dr. Namandjé Bumpus, Johns Hopkins Medicine

Valproic acid is one of the most widely prescribed drugs for the treatment of epilepsy. It has also been shown to be effective for the treatment of mood disorders and migraine headaches.

17 Feb 2014

Commonly-used HIV drug kills HPV that leads to cervical cancer

A commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital in Nairobi.

17 Feb 2014

The obese, people with AIDS encounter coverage gaps

Many plans sold through the health law's marketplaces don't cover weight loss surgery, and none in Louisiana are accepting payments from a federal program intended to help people with HIV/AIDS. The New York Times explores who benefits from the latest employer mandate extension, and Kaiser Health News answers a question about the health law's impact on a person covered by COBRA.

17 Feb 2014

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

16 Feb 2014

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.

14 Feb 2014

Persons with severe symptoms of mental illness are at higher risk for being HIV-infected

People receiving mental health care are up to four times more likely to be infected with HIV than the general population, according to a new study published Feb. 13 in the American Journal of Public Health from researchers at Penn Medicine and other institutions who tested over 1,000 patients in care in Philadelphia and Baltimore.

14 Feb 2014

South African pediatrician receives 2013 Scientific Freedom and Responsibility Award from AAAS

Hoosen Coovadia, a South African pediatrician and research scientist, and international authority on HIV/AIDS, particularly mother-to-child transmission, has been named recipient of the 2013 Scientific Freedom and Responsibility Award from the American Association for the Advancement of Science.

13 Feb 2014

Researchers examine whether spirituality has role to play in prevention of addictions

Spirituality is a central tenet of 12-step recovery programs like Alcoholics Anonymous. Its value, particularly regarding alcohol addiction, has been recognized by many health care practitioners as well.

13 Feb 2014

Study provides first empirical evidence that foreign aid can greatly improve foreign public opinion

A study by Dartmouth and Australian researchers provides the first empirical evidence using data from a variety of countries that foreign aid can greatly improve foreign public opinion of donor countries.

12 Feb 2014

Biologists demonstrate highly effective method for delivering HIV-fighting antibodies

In 2011, biologists at the California Institute of Technology (Caltech) demonstrated a highly effective method for delivering HIV-fighting antibodies to mice-a treatment that protected the mice from infection by a laboratory strain of HIV delivered intravenously.

12 Feb 2014

Scientists find neutralizing antibodies that protects humanized mice from HIV transmission

NIH-funded scientists have shown that boosting the production of certain broadly neutralizing antibodies can protect humanized mice from both intravenous and vaginal infection with HIV. Humanized mice have immune systems genetically modified to resemble those of humans, making it possible for them to become HIV-infected.

12 Feb 2014

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.

11 Feb 2014

Tamoxifen drug appears to kill fungus associated with deadly brain infection

The drug tamoxifen appears to kill a fungus associated with a deadly brain infection that afflicts HIV/AIDS patients, according to a University of Rochester study published online today by mBio, the journal of the American Society for Microbiology.

11 Feb 2014

Colour-changing ABC Syringe shortlisted for 2014 World Design Impact Prize

University of Huddersfield lecturer Dr David Swann's design for a syringe that changes colour in order to deter its re-use - with the possibility of spreading dangerous infection - has already earned global interest. Now the project's profile will be raised higher still, following its shortlisting for a second major design award.

11 Feb 2014

Health people engages in 2 new initiatives to bring down overall women's HIV/AIDS infection rate

With the Bronx still having the highest rate of new women's HIV/AIDS cases of any New York City borough, Health People: Community Preventive Health Institute is engaged in two important new initiatives to provide prevention and services to women in greatest need. Both offer great potential to develop better strategies to assure the Bronx brings down its overall women's HIV/AIDS infection rate.

11 Feb 2014

Dental care in schools for children wipes out social inequities

A new survey conducted by the University of Copenhagen and the World Health Organization (WHO) is highlighting the role of schools in work to promote health and prevent disease.

11 Feb 2014

Drug used for treating breast cancer also kills fungal disease

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more HIV/AIDS patients than tuberculosis, appear in mBio-, the online open-access journal of the American Society for Microbiology (ASM.)

11 Feb 2014

New AAA screening program reduces number of undiagnosed at-risk men by more than 50%

A screening program for abdominal aortic aneurysms, integrated into an electronic health record, dramatically reduced the number of unscreened at-risk men by more than 50 percent within 15 months, according to a Kaiser Permanente study published today in the Journal of Vascular Surgery. An abdominal aortic aneurysm is a balloon-like bulge in the aorta, which - if ruptured - can result in death.

10 Feb 2014

Obamacare tweaks continue amid complaints

The government will allow consumers who experience life changes, such as a marriage or the birth of a child, to update their plan choices, the administration said. It is also looking at requiring insurers to accept third-party payments, such as those made under the Ryan White CARE Act, to help people with HIV/AIDS pay for expensive drugs. Meanwhile, The Washington Post examines the history of Accenture, the contractor hired to fix healthcare.gov, and finds troubled projects and allegations of ethical lapses.

10 Feb 2014

HIV News and Research

New approach for delivering vaccines and for stimulating body's immune system to attack tumors

Valproic acid metabolism and obesity: an interview with Dr. Namandjé Bumpus, Johns Hopkins Medicine

Commonly-used HIV drug kills HPV that leads to cervical cancer

The obese, people with AIDS encounter coverage gaps

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Persons with severe symptoms of mental illness are at higher risk for being HIV-infected

South African pediatrician receives 2013 Scientific Freedom and Responsibility Award from AAAS

Researchers examine whether spirituality has role to play in prevention of addictions

Study provides first empirical evidence that foreign aid can greatly improve foreign public opinion

Biologists demonstrate highly effective method for delivering HIV-fighting antibodies

Scientists find neutralizing antibodies that protects humanized mice from HIV transmission

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

Tamoxifen drug appears to kill fungus associated with deadly brain infection

Colour-changing ABC Syringe shortlisted for 2014 World Design Impact Prize

Health people engages in 2 new initiatives to bring down overall women's HIV/AIDS infection rate

Dental care in schools for children wipes out social inequities

Drug used for treating breast cancer also kills fungal disease

New AAA screening program reduces number of undiagnosed at-risk men by more than 50%

Obamacare tweaks continue amid complaints

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News